Cargando…
Absence of constitutive EGF receptor activation in ovarian cancer cell lines.
Previous investigators have noted that certain ovarian cancer cell lines secrete and respond to transforming growth factor-alpha (TGF-alpha), suggesting that endogenous activation of the epidermal growth factor (EGF) receptor through autocrine or paracrine mechanisms might contribute to the prolifer...
Autores principales: | Ottensmeier, C., Swanson, L., Strobel, T., Druker, B., Niloff, J., Cannistra, S. A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074650/ https://www.ncbi.nlm.nih.gov/pubmed/8695362 |
Ejemplares similares
-
Ligand regulation of a constitutively dimeric EGF receptor
por: Freed, Daniel M., et al.
Publicado: (2015) -
Targeting the EGF Receptor for Ovarian Cancer Therapy
por: Zeineldin, Reema, et al.
Publicado: (2010) -
Teriflunomide Is an Indirect Human Constitutive Androstane Receptor (CAR) Activator Interacting With Epidermal Growth Factor (EGF) Signaling
por: Carazo, Alejandro, et al.
Publicado: (2018) -
Discovery of HB-EGF binding peptides and their functional characterization in ovarian cancer cell lines
por: Shen, Yanting, et al.
Publicado: (2019) -
Increased EGF receptors on human squamous carcinoma cell lines.
por: Cowley, G. P., et al.
Publicado: (1986)